drugset / Trial / NCT04603456

miRNA-155 Assay Before and After Immunotherapy and Probiotics

NCT04603456

Phase 4 Completed 45 enrolled Zagazig University
RandomizedParallel-groupOpen-labelOther

Summary

The investigators aimed to explore miRNA-155 change in response to sublingual immunotherapy (SLIT), probiotics and combined treatment with SLIT and probiotics in AR children.

Timeline

Start
2018-09-01
Primary completion
2019-03-10
Completion
2019-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacteol fort Unknown 1e+10 cells
Subject Phleum pratense pollen extract Unknown Intranasal

Indications